Mustang Bio Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Welcome to day two of Chardan's fifth annual genetic medicines conference. Our compliance department has asked us to read the following message before we get started. Ideas and recommendations presented are solely those of the presenter and not Chardan. Presenters have been advised not to discuss any confidential or material nonpublic information. Additionally, any KOL speaking may have investments or other interests in the names that they discussed.
With that out of the way, it's my pleasure to introduce our next guest from Mustang Bio, President and Chief Executive Officer, Dr. Manny Litchman; Chief Technical Officer, Dr. Knut Niss; VP -- Senior VP, Head of Clinical Development, Dr. Bruce Dezube; and Senior VP of Finance and Corporate Controller, Mr. Brian Achenbach.
The format for this session is a roughly 25-minute fireside chat. If any of our audience attendees have questions during the session, feel free to type them into the question box under the video player, and we will try to ask them on your behalf.
So with that,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |